MORGAN STANLEY - 31 Mar 2025 SCHEDULE 13G/A Report for Tarsus Pharmaceuticals, Inc. Common Stock (TARS)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: Tarsus Pharmaceuticals, Inc. Common Stock
Symbol: TARS
Shares outstanding: 41,350,064 shares
Disclosed Ownership: 1,943,453 shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Filing time: 07 May 2025, 11:27:44 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	4.7%	1,943,453	0	1,932,256	Christopher O'Hara	Authorized Signatory, Morgan Stanley